Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
1.275
+0.015 (1.19%)
May 27, 2026, 1:29 PM EDT - Market open
Health Catalyst Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Health Catalyst stock has a consensus rating of "Hold" and an average price target of $1.75. The average 1-year stock price forecast is 37.25% higher than the current stock price, while the lowest is $1.00 (-21.57%) and the highest is $2.00 (+56.86%).
Price Target: $1.75 (+37.25%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Health Catalyst stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 8 | 8 | 7 | 7 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 11 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 19, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $2 | Hold | Maintains | $2 | +56.86% | May 12, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $2 | Buy | Maintains | $2 | +56.86% | May 12, 2026 |
| Stephens | Stephens | Hold Maintains $2 → $1.75 | Hold | Maintains | $2 → $1.75 | +37.25% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2 | Hold | Reiterates | $2 | +56.86% | May 12, 2026 |
Financial Forecast
Revenue This Year
272.06M
from 311.14M
Decreased by -12.56%
Revenue Next Year
255.41M
from 272.06M
Decreased by -6.12%
EPS This Year
0.10
from -2.55
EPS Next Year
0.20
from 0.10
Increased by 92.50%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 307.3M | 304.3M | |
| Avg | 272.1M | 255.4M | |
| Low | 255.5M | 216.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.2% | 11.8% | |
| Avg | -12.6% | -6.1% | |
| Low | -17.9% | -20.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.23 | 0.55 | |
| Avg | 0.10 | 0.20 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 435.3% | |
| Avg | - | 92.5% | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.